A biotech startup led by former Biogen Inc. and Amgen Inc. executive Jo Viney is pushing into autoimmune diseases with the help of $121 million in new funds.
Seismic Therapeutic Inc., which emerged from stealth in February 2022, announced its Series B on Monday. It's easily one of the largest venture capital raises of the year amid a tough market for young biotechs.
Bessemer Venture Partners led the round. The venture arm of Amgen, where Viney once led inflammation research, joined in, as did Codon…
